HOME
CAREERS
CONTACT US
KOREAN
ENGLISH
KR
EN
Toggle navigation
COMPANY
ABOUT US
MANAGEMENT
HISTORY
BOARD OF DIRECTORS
SCIENTIFIC ADVISORY BOARD
SCIENCE
PIPELINE
COLLABORATION
INVESTORS
NOTICE
PRESENTATION
GENERAL MEETING
OF STOCKHOLDERS
INDEPENDENT
AUDITOR'S REPORT
CONTACT IR
MEDIA
NEWS
VIDEO SOURCE
ESG
NeoImmuneTech is
Expanding the Horizon of Immuno-Oncology and
Enhancing Immunity to Infectious Diseases
Learn more about our company
NT-I7
, Our Lead Drug Candidate, is
a Unique T Cell Amplifier
Learn more about our science
Advancing Clinical Development
in Oncology and Immunology
Learn more about our clinical trials